Status:
COMPLETED
Anti-Secretory Drug in Treatment of Acute Watery Diarrhea
Lead Sponsor:
Assiut University
Conditions:
Acute Watery Diarrhea
Eligibility:
All Genders
6-5 years
Phase:
PHASE1
Brief Summary
In conclusion, racecadotril is an anti-secretory drug that exerts its antidiarrheal effect by inhibiting intestinal enkephalinase. It is effective in reducing the volume and frequency of stool output....
Detailed Description
Background: Previous studies have shown that racecadotril is a safe and effective drug in treating children with acute diarrhea. Study Aim: to evaluate the effect of racecadotril as an adjunct to oral...
Eligibility Criteria
Inclusion
- Age group for six months - 5 years.
- No or mild to moderate dehydration.
- Alert patient (to tolerate oral intake since the drug is only available in oral form).
Exclusion
- Patients with severe dehydration (inability to drink because of drowsiness).
- Patients with any serious concomitant illness that needs antibiotic treatment.
- If severe adverse events occur at any time.
- Chronic diarrhea.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05216822
Start Date
June 1 2018
End Date
August 31 2018
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt, 71511